Lexeo Therapeutics, Inc. · NASDAQ:LXEO

James N. Topper reported a 9.90% stake in Lexeo Therapeutics, Inc. (Schedule 13G)

Event May 28, 2025 · Filed Jun 4, 2025

James N. Topper reported a 9.90% stake in Lexeo Therapeutics, Inc., 5,500,812 shares, as a passive investor on May 28, 2025. Filed Jun 4, 2025 (Schedule 13G).

Stake
9.90%
Shares
5,500,812
Intent
Passive
What changed
Crossed above 5%
Filed together
20 holders

The filing in full

HolderStakeShares
Frazier Life Sciences Public Fund, L.P.6.80%3,730,419
FHMLSP, L.P.6.80%3,730,419
FHMLSP, L.L.C.6.80%3,730,419
Frazier Life Sciences Public Overage Fund, L.P.1.50%818,607
FHMLSP Overage, L.P.1.50%818,607
FHMLSP Overage, L.L.C.1.50%818,607
Frazier Life Sciences X, L.P.0.20%114,541
FHMLS X, L.P.0.20%114,541
FHMLS X, L.L.C.0.20%114,541
Frazier Life Sciences XI, L.P.0.60%304,989
FHMLS XI, L.P.0.60%304,989
FHMLS XI, L.L.C.0.60%304,989
Frazier Life Sciences XII, L.P.1.00%532,256
FHMLS XII, L.P.1.00%532,256
FHMLS XII, L.L.C.1.00%532,256
James N. Topper9.90%5,500,812
Patrick J. Heron9.90%5,500,812
Albert Cha8.30%4,549,026
James Brush8.30%4,549,026
Daniel Estes1.50%837,245

Source

View original at SEC

Related